Plus TherapeuticsCNSY
13F holders, Q4 2024 (December 31)11holders
1new positions
2sold out
$1.15avg. 13F price*
At the end of Q4 2024, 11 institutions reported holding Plus Therapeutics Inc. (CNSY) in their 13F filings, unchanged from Q3 2024. 1 opened new positions and 2 sold out. The largest holders were AIGH Capital Management LLC ($645K), Geode Capital Management, LLC ($67K) and Vanguard Group Inc. ($37K).
- Company
- Plus Therapeutics Inc.
- CUSIP
- 72941H509
- Latest filing quarter
- Q1 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $17K |
| Exits | 2 | $19K |
All 13F filers, Q3 2024 → Q4 2024: 19,536 shares bought and 13,013 shares sold, net +6,523 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 11 holders
| AIGH Capital Management LLC | 0.24% | No change | 560,905 | $645K |
| Geode Capital Management, LLC | 0.00% | Add +7.1% | 58,150 | $67K |
| Vanguard Group Inc. | 0.00% | No change | 32,541 | $37K |
| Two Sigma Securities, LLC | 0.00% | New | 14,587 | $17K |
| BlackRock, Inc. | 0.00% | No change | 6,960 | $8K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +28.9% | 4,782 | $5K |
| Osaic Holdings, Inc. | 0.00% | No change | 133 | $152 |
| SBI Securities Co., Ltd. | 0.00% | — | 66 | $76 |
| Bank of America Corp. | 0.00% | No change | 48 | $55 |
| Danske Bank A/S | 0.00% | No change | 1 | $1 |
| Group One Trading LLC | 0.00% | No change | 1 | $1 |
"% of holder's portfolio" is CNSY's weight in each manager's 13F, not the share of Plus Therapeutics Inc. the manager owns.